Applied Molecular Transport Reports Third Quarter 2023 Financial Results
Provided By GlobeNewswire
Last update: Nov 9, 2023
Company Entered into Definitive Merger Agreement with Cyclo Therapeutics
Cash and Cash Equivalents of $18.1 million, as of September 30, 2023
Read more at globenewswire.com
